We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Iris Energy
IREN
$10.5B
| $293K | ﹤0.01% |
+95,773
| New | +$235K |
|
2277
Penske Automotive Group
PAG
$14.7B
| $293K | ﹤0.01% |
2,065
-6,334
| -75% | -$843K |
|
|
GAMB
2278
DELISTED
Gambling.com
GAMB
| $292K | ﹤0.01% |
29,500
-2,100
| -7% | -$20.2K |
|
2279
Smart Sand
SND
$179M
| $292K | ﹤0.01% |
165,983
+79,275
| +91% | +$147K |
|
2280
Nano X Imaging
NNOX
$61.1M
| $292K | ﹤0.01% |
+50,535
| New | +$386K |
|
2281
Distribution Solutions Group
DSGR
$1.6B
| $291K | ﹤0.01% |
12,810
-8,156
| -39% | -$171K |
|
2282
Inter&Co
INTR
$2.39B
| $286K | ﹤0.01% |
+168,398
| New | +$352K |
|
|
DMTK
2283
DELISTED
DermTech, Inc. Common Stock
DMTK
| $286K | ﹤0.01% |
77,780
+7,103
| +10% | +$29.9K |
|
2284
PUT
Vanguard Morningstar Total Stock Market ETF
VTI
$646B
| $286K | ﹤0.01% |
+1,400
| New | +$280K |
|
|
SMMF
2285
DELISTED
Summit Financial Group, Inc.
SMMF
| $284K | ﹤0.01% |
+13,710
| New | +$334K |
|
2286
Northeast Community Bancorp
NECB
$373M
| $284K | ﹤0.01% |
+21,669
| New | +$325K |
|
|
CWBC
2287
Community West Bancshares
CWBC
$685M
| $282K | ﹤0.01% |
+13,717
| New | +$319K |
|
2288
Establishment Labs
ESTA
$2.71B
| $282K | ﹤0.01% |
4,157
-2,100
| -34% | -$144K |
|
2289
CALL
Walt Disney
DIS
$171B
| $280K | ﹤0.01% |
2,800
-63,800
| -96% | -$6.43M |
|
2290
Boston Beer
SAM
$1.95B
| $279K | ﹤0.01% |
848
-13,355
| -94% | -$4.59M |
|
2291
Crescent Capital BDC
CCAP
$405M
| $278K | ﹤0.01% |
20,413
+7,777
| +62% | +$113K |
|
|
STWOW
2292
CALL
DELISTED
ACON S2 Acquisition Corp Warrant
STWOW
| $278K | ﹤0.01% |
200,000
| – | – |
|
|
CMLS
2293
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $278K | ﹤0.01% |
75,337
+22,033
| +41% | +$124K |
|
2294
TH International
THCH
$57.7M
| $276K | ﹤0.01% |
+13,549
| New | +$273K |
|
|
DZSI
2295
DELISTED
DZS Inc. Common Stock
DZSI
| $275K | ﹤0.01% |
+34,861
| New | +$388K |
|
|
KRON
2296
DELISTED
Kronos Bio
KRON
| $275K | ﹤0.01% |
188,201
-11,407
| -6% | -$21.9K |
|
|
CBIO
2297
Crescent Biopharma
CBIO
$546M
| $273K | ﹤0.01% |
2,163
+74
| +4% | +$16.7K |
|
2298
Arch Capital
ACGL
$35.7B
| $271K | ﹤0.01% |
+4,000
| New | +$263K |
|
2299
Vor Biopharma
VOR
$1.06B
| $269K | ﹤0.01% |
2,504
+980
| +64% | +$109K |
|
2300
Dole
DOLE
$1.38B
| $269K | ﹤0.01% |
+22,953
| New | +$257K |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.